| Pachner AR, Warth JD, Pace A, et al.
Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study. [Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Neurology 2009 Nov 3; 73(18):1493-500.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pachner AR, Cadavid D, Wolansky L, et al.
Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Neurology 2009 Nov 3; 73(18):1485-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hsu CS, Kao JH
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1808-9; author reply 1809.
Full Citation | Find Related Articles | | Breilh D, Djabarouti S, Trimoulet P, et al.
Ribavirin Plasma Concentration Predicts Sustained Virological Response to Peginterferon Alfa 2a Plus Ribavirin in Previously Treated HCV-HIV-Coinfected Patients. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov; 52(3):428-430.
Full Citation | Find Related Articles | | Trojano M, Pellegrini F, Paolicelli D, et al.
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. [Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Ann Neurol 2009 Oct; 66(4):513-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Korczyn AD
Re: Practice parameters and technology assessments: what they are, what they are not, and why you should care. [Comment, Letter]
Neurology 2009 Oct 20; 73(16):1336; author reply 1336-7.
Full Citation | Publisher Full Text | Find Related Articles | | Stüve O, Ransohoff RM
Immunotherapy for multiple sclerosis: the curious case of interferon beta. [Comment, Editorial]
Arch Neurol 2009 Oct; 66(10):1193-4.
Full Citation | Publisher Full Text | Find Related Articles | | Barakat FM, McDonald V, Foster GR, et al.
Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon. [Journal Article, Research Support, Non-U.S. Gov't]
J Infect Dis 2009 Nov 15; 200(10):1548-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Miller DH, Leary SM
Treatment of clinically isolated syndrome: to be PreCISe. [Comment, Journal Article]
Lancet 2009 Oct 31; 374(9700):1475-6.
Full Citation | Find Related Articles | | Post JW, Colleaux K
Interferon beta retinopathy in a patient with multiple sclerosis. [Letter]
Can J Ophthalmol 2009 Oct; 44(5):e37.
Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
